TrialCancer2012

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial.

Maria E Cabanillas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.